Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PTC Therapeutics Affirms FY2025 Sales Guidance of $650.00M-$800.00M vs $1.75B Est

Author: Benzinga Newsdesk | August 07, 2025 04:02pm
PTC Therapeutics (NASDAQ:PTCT) affirms FY2025 sales outlook from $650.00 million-$800.00 million to $650.00 million-$800.00 million vs $1.75 billion estimate.

Posted In: PTCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist